Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis

References

• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094–108.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205–19.
   PubMed Web of Science ®Google Scholar
• Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1961–9.
   Google Scholar
• Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133–41.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453:1051–7.
   PubMed Web of Science ®Google Scholar
• van Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM, Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum 2011;63:73–83.
   PubMed Web of Science ®Google Scholar
• Shen H, Goodall JC, Hill GJ. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009;60:1647–56.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li JM, Liu XG, Ma DX, Hu NW, Li YG, Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011;31:606–14.
   PubMed Web of Science ®Google Scholar
• Jiao Z, Hua S, Wang W, Wang H, Gao J, Wang X. Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Scand J Rheumatol 2013;42:85–90.
   PubMed Web of Science ®Google Scholar
• Lubberts E, Koenders MI, van den Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 2005;7:29–37.
   PubMed Web of Science ®Google Scholar
• Waldburger JM, Firestein GS. Garden of therapeutic delights: new targets in rheumatic diseases. Arthritis Res Ther 2009;11:206.
   PubMed Web of Science ®Google Scholar
• Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008;205:1903–16.
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009;206:525–34.
   PubMed Web of Science ®Google Scholar
• Lanier LL, Chang C, Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994; 153:2417–28.
   PubMed Web of Science ®Google Scholar
• Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 2010;40:2174–81.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011;63:2504–15.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ‘t Hof, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
   Google Scholar
• Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744–8.
   PubMed Web of Science ®Google Scholar
• Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007;204:41–7.
   PubMed Web of Science ®Google Scholar
• Shahrara S, Huang Q, Mandelin AN, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008;10:R93.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345–50.
   PubMed Web of Science ®Google Scholar
• Dong W, Zhu P. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics. Autoimmun Rev 2012; 11:844–51.
   PubMed Web of Science ®Google Scholar
• Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160:3513–21.
   PubMed Web of Science ®Google Scholar
• Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, Lowik CW. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis 2002;61:870–6.
   PubMed Web of Science ®Google Scholar
• Metawi SA, Abbas D, Kamal MM, Ibrahim MK. Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 2011; 30:1201–7.
   PubMed Web of Science ®Google Scholar
• Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010;62:929–39.
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942–9.
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950–7.
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967–74.
   PubMed Web of Science ®Google Scholar
• Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, Late developmental plasticity in the T helper 17 lineage. Immunity 2009;30:92–107.
   PubMed Web of Science ®Google Scholar
• Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 2010; 107:14751–6.
   PubMed Web of Science ®Google Scholar
• Toh ML, Kawashima M, Hot A, Miossec P, Miossec P. Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition. Ann Rheum Dis 2010;69:1562–7.
   PubMed Web of Science ®Google Scholar
• Lina C, Conghua W, Nan L, Ping Z. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol 2011;31: 596–605.
   PubMed Web of Science ®Google Scholar
• E XQ, Meng HX, Cao Y, Zhang SQ, Bi ZG, Yamakawa M. Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis. Scand J Rheumatol 2012;41:413–20.
   PubMed Web of Science ®Google Scholar
• Schulze-Koops H, Kalden JR. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15: 677–91.
   PubMed Web of Science ®Google Scholar
• Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010;12:R53.
   PubMed Web of Science ®Google Scholar